WHO ICTRP trial
To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol…
KCT0000540 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0000540 |
|---|---|
| Public title | To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men |
| Scientific title | Phase I study to Determine the Safety and Immunogenicity of Euvichol(Oral Cholera Prevention Vaccine)in Healthy Adult Men ; Open, Non-comparative clinical trial |
| Primary sponsor | Eubiologics |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1 |
| Countries | Korea, Republic of |
| Conditions | Not Applicable |
| Interventions | Biological/Vaccine : Euvichol(Oral cholera vaccine), 1vial(1.5mL), Administered orally twice at 2-week intervals(Total 2vials) |
| Registration date | Sep 20, 2012 |
| Target size | 20 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: